A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma

We report on a case of severe hepatotoxicity in a 52-year-old male with multiple myeloma (MM) who had received bortezomib therapy. At patient presentation, liver enzymes were normal, but started to markedly increase 3 days after the patient's second dose of bortezomib was administered, when fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youngwoon, Kim, Ka Young, Lee, Su Hyun, Chung, Yoon Yung, Yahng, Seung-Ah, Lee, Sung-Eun, Park, Gyeongsin, Min, Chang-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422711/
https://www.ncbi.nlm.nih.gov/pubmed/22916049
http://dx.doi.org/10.4110/in.2012.12.3.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422711/
https://www.ncbi.nlm.nih.gov/pubmed/22916049
http://dx.doi.org/10.4110/in.2012.12.3.126

Ejemplares similares